Medical Treatment of Malignancy-Associated Hypercalcemia

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|15|4|415-421

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.15, Iss.4, 2008-02, pp. : 415-421

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Comparative Study of Incadronate and Elcatonin in Patients with Malignancy-associated Hypercalcaemia

By Matsumoto T   Nagata N   Horikoshi N   Adachi I   Ohashi Y   Ogata E  

The Journal of International Medical Research, Vol. 30, Iss. 3, 2002-05 ,pp. : 230-243

Field House Publishing

Access to resources Recommend Favorite

Treatment of Acute Hypercalcemia

By  

Medicinal Chemistry, Vol. 8, Iss. 4, 2012-01 ,pp. : 564-568

Bentham Science Publishers

Access to resources Recommend Favorite

Treatment of Chronic Hypercalcemia

By  

Medicinal Chemistry, Vol. 8, Iss. 4, 2012-07 ,pp. : 556-563

Bentham Science Publishers

Access to resources Recommend Favorite

Infectious Complications Associated With Immunomodulating Monoclonal Antibodies Used in the Treatment of Hematologic Malignancy

By Koo Sophia   Baden Lindsey R.  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 2, 2008-02 ,pp. : 202-213

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Editorial [Hot Topic: Calcium Metabolism and Treatment of Hypercalcemia]

By  

Medicinal Chemistry, Vol. 8, Iss. 4, 2012-07 ,pp. : 549-550

Bentham Science Publishers

Access to resources Recommend Favorite